期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

DPP-4抑制剂与心血管疾病:利与弊 被引量：2

下载PDF
导出
摘要 糖尿病是心血管疾病的高危因素，糖尿病患者因心血管疾病的死亡率高达70％。与非糖尿病人群相比，糖尿病男性患者发生心血管疾病的危险率高2—3倍，女性患者高3～4倍。因而预防和治疗心血管疾病，
作者 阎胜利 胡文超
机构地区 青岛大学医学院附属医院内分泌科
出处 《实用糖尿病杂志》 2012年第6期5-8,共4页 Journal of Practical Diabetology
关键词 心血管疾病 非糖尿病人群 抑制剂 男性患者 高危因素 女性患者 死亡率 危险率
分类号 R587.1 [医药卫生—内分泌] R54 [医药卫生—心血管疾病]
  • 相关文献

参考文献27

  • 1Ford ES. Risks for all - cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005 ;28 (7) : 1769 - 1778.
  • 2Manson JE, Colditz GA, Stampfer MJ, et al. A prospective study of maturity - onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991;151(6) :1141 - 1147.
  • 3Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12 - yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993 ; 16 ( 2 ) : 434 - 444.
  • 4Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360(2) :129 -39.
  • 5ADVANCE Collaborative Group, Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358(24) :2560 -2572.
  • 6ACCORD Study Group, Gerstein HC, Miller ME, et al. Long - term effects of intensive glucose lowering on cardiovascular outcomes. N Engl J Med 2011 ;364(9) :818 -828.
  • 7Green JB. The dipeptidyl peptidase - 4 inhibitors in type 2 diabetes mellitus: cardiovascular safety. Postgrad Med 2012;124(4) : 54 - 61.
  • 8Ban K, Noyan - Ashraf MH, Hoefer J, et al. Cardioprotectire and vasodilatory actions of glucagon - like peptide 1 receptor are mediated through both glucagon - like peptide 1 receptor - dependent and - independent pathways. Circulation 2008 ; 117 ( 18 ) :2340 - 2350.
  • 9Eeg - Olofsson K, Cederholm J, Nilsson PM, et al. Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients. Diabetologia 2009 ;52( 1 ) ;65 -73.
  • 10Pratley R, Nauck M, Bailey T, et al. One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel - group, open -label trial. Int J Clin Pratt 2011 ;65(4) :397 -407.

同被引文献10

二级引证文献49

实用糖尿病杂志
2012年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部